(Q44317809)

1 December 2017

title

Glucose screening and the risk of complications in Type 2 diabetes mellitus (English)

1 reference

1 December 2017

1 reference

3

Noel S Weiss

1 reference

1 December 2017

Kenneth G Schellhase

1

1 reference

1 December 2017

Thomas D Koepsell

series ordinal

2

1 reference

1 December 2017

Edward H Wagner

series ordinal

4

1 reference

1 December 2017

Gayle E Reiber

series ordinal

5

1 reference

1 December 2017

publication date

1 January 2003

1 reference

Journal of Clinical Epidemiology

1 December 2017

published in

1 reference

1 December 2017

volume

56

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

75-80

1 reference

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900533-4

7 January 2021

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900533-4

7 January 2021

Undiagnosed NIDDM: clinical and public health issues.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900533-4

7 January 2021

Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900533-4

7 January 2021

Hyperglycemia and microvascular and macrovascular disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900533-4

7 January 2021

Relation of glycemic control to diabetic complications and health outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900533-4

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900533-4

7 January 2021

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900533-4

7 January 2021

Estimated benefits of glycemic control in microvascular complications in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900533-4

7 January 2021

Screening for NIDDM in nonpregnant adults. A review of principles, screening tests, and recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900533-4

7 January 2021

Screening for diabetes: what are we really doing?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900533-4

7 January 2021

Application of the case-control method in the evaluation of screening

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900533-4

7 January 2021

A Case–Control Study of Screening Sigmoidoscopy and Mortality from Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900533-4

7 January 2021

Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900533-4

7 January 2021

Screening digital rectal examination and prostate cancer mortality: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900533-4

7 January 2021

A case-control study to evaluate efficacy of screening for faecal occult blood

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900533-4

7 January 2021

Analysis of case-control studies of screening: impact of misspecifying the duration of detectable preclinical pathologic changes.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900533-4

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900533-4

7 January 2021

10.1016/S0895-4356(02)00533-4

Identifiers

DOI

1 reference

1 December 2017

1 reference